Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
A multicenter, prospective, open-label, blinded endpoint, randomized controlled trial aiming
at evaluating the efficacy and safety of intra-arterial recombinant human tissue plasminogen
activator (rt-PA) after successful recanalization of acute large vessel occlusion in the
anterior circulation by mechanical thrombectomy in improving the 90-day functional outcome.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University